What is PYYX's health score?

PYXUS INTERNATIONAL, INC. (PYYX) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PYYX's estimated fair value?

Based on our 5-year discounted cash flow model, PYXUS INTERNATIONAL, INC.'s estimated fair value is $16.43 per share, representing a 421.6% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is PYYX undervalued or overvalued?

Our model currently rates PYYX as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PYYX... Refresh in a moment for the full analysis.

PYXUS INTERNATIONAL, INC. (PYYX)

Industrials Undervalued low weak

$3.15

Updated: 2026-06-05

TradeApes Score

Financial Strength

0 Stressed

Operating Trend

35 Weak

Relative Value

70 Healthy

Capital Allocation

55 Mixed

Risk

50 Mixed

Est. Fair Value $16.43

DCF Upside +421.6%

Sector Rank #365 of 3839

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.